Literature DB >> 27915396

Accurate stone analysis: the impact on disease diagnosis and treatment.

Neil S Mandel1, Ian C Mandel2, Ann M Kolbach-Mandel2.   

Abstract

This manuscript reviews the requirements for acceptable compositional analysis of kidney stones using various biophysical methods. High-resolution X-ray powder diffraction crystallography and Fourier transform infrared spectroscopy (FTIR) are the only acceptable methods in our labs for kidney stone analysis. The use of well-constructed spectral reference libraries is the basis for accurate and complete stone analysis. The literature included in this manuscript identify errors in most commercial laboratories and in some academic centers. We provide personal comments on why such errors are occurring at such high rates, and although the work load is rather large, it is very worthwhile in providing accurate stone compositions. We also provide the results of our almost 90,000 stone analyses and a breakdown of the number of components we have observed in the various stones. We also offer advice on determining the method used by the various FTIR equipment manufacturers who also provide a stone analysis library so that the FTIR users can feel comfortable in the accuracy of their reported results. Such an analysis on the accuracy of the individual reference libraries could positively influence the reduction in their respective error rates.

Entities:  

Keywords:  Calcium oxalate; FTIR; Kidney stone analysis; Uric acid; X-ray diffraction

Mesh:

Year:  2016        PMID: 27915396     DOI: 10.1007/s00240-016-0943-0

Source DB:  PubMed          Journal:  Urolithiasis        ISSN: 2194-7228            Impact factor:   3.436


  13 in total

1.  The amount and nature of the organic matrix in urinary calculi: a review.

Authors:  W H BOYCE; F K GARVEY
Journal:  J Urol       Date:  1956-09       Impact factor: 7.450

2.  Analysis of mixed stones is prone to error: a study with US laboratories using micro CT for verification of sample content.

Authors:  Amy E Krambeck; James E Lingeman; James A McAteer; James C Williams
Journal:  Urol Res       Date:  2010-10-22

3.  Guaifenesin stone matrix proteomics: a protocol for identifying proteins critical to stone formation.

Authors:  A M Kolbach-Mandel; N S Mandel; S R Cohen; J G Kleinman; F Ahmed; I C Mandel; J A Wesson
Journal:  Urolithiasis       Date:  2016-07-19       Impact factor: 3.436

4.  Quality control in urinary stone analysis: results of 44 ring trials (1980-2001).

Authors:  Albrecht Hesse; Rolf Kruse; Wolf-Jochen Geilenkeuser; Matthias Schmidt
Journal:  Clin Chem Lab Med       Date:  2005       Impact factor: 3.694

5.  Efavirenz-induced urolithiasis.

Authors:  G J Wirth; J Teuscher; J D Graf; C E Iselin
Journal:  Urol Res       Date:  2006-04-20

6.  Triamterene-induced nephrolithiasis.

Authors:  B Ettinger; E Weil; N S Mandel; S Darling
Journal:  Ann Intern Med       Date:  1979-11       Impact factor: 25.391

7.  Lipids and membranes in the organic matrix of urinary calcific crystals and stones.

Authors:  S R Khan; F Atmani; P Glenton; Z Hou; D R Talham; M Khurshid
Journal:  Calcif Tissue Int       Date:  1996-11       Impact factor: 4.333

8.  Urolithiasis in patients on high dose felbamate.

Authors:  Anas I Ghousheh; Travis W Groth; Kathy M Fryjoff; David F Wille; Neil S Mandel; John T Roddy; Charles T Durkee
Journal:  J Urol       Date:  2012-12-21       Impact factor: 7.450

9.  Quality Assessment of Urinary Stone Analysis: Results of a Multicenter Study of Laboratories in Europe.

Authors:  Roswitha Siener; Noor Buchholz; Michel Daudon; Bernhard Hess; Thomas Knoll; Palle J Osther; José Reis-Santos; Kemal Sarica; Olivier Traxer; Alberto Trinchieri
Journal:  PLoS One       Date:  2016-06-01       Impact factor: 3.240

Review 10.  Metabolic diagnosis and medical prevention of calcium nephrolithiasis and its systemic manifestations: a consensus statement.

Authors:  Giovanni Gambaro; Emanuele Croppi; Fredric Coe; James Lingeman; Orson Moe; Elen Worcester; Noor Buchholz; David Bushinsky; Gary C Curhan; Pietro Manuel Ferraro; Daniel Fuster; David S Goldfarb; Ita Pfeferman Heilberg; Bernard Hess; John Lieske; Martino Marangella; Dawn Milliner; Glen M Preminger; Jose' Manuel Reis Santos; Khashayar Sakhaee; Kemal Sarica; Roswitha Siener; Pasquale Strazzullo; James C Williams
Journal:  J Nephrol       Date:  2016-07-25       Impact factor: 3.902

View more
  9 in total

1.  Are conventional stone analysis techniques reliable for the identification of 2,8-dihydroxyadenine kidney stones? A case series.

Authors:  Hrafnhildur L Runolfsdottir; Tzu-Ling Lin; David S Goldfarb; John A Sayer; Mini Michael; David Ketteridge; Peter R Rich; Vidar O Edvardsson; Runolfur Palsson
Journal:  Urolithiasis       Date:  2020-05-12       Impact factor: 3.436

2.  Intestinal dysbacteriosis leads to kidney stone disease.

Authors:  Enyang Zhao; Wenfu Zhang; Bo Geng; Bosen You; Wanhui Wang; Xuedong Li
Journal:  Mol Med Rep       Date:  2020-12-31       Impact factor: 2.952

3.  Study of risk factor of urinary calculi according to the association between stone composition with urine component.

Authors:  Pan Wang; Hongxian Zhang; Jiansuo Zhou; Shangjia Jin; Chong Liu; Boxin Yang; Liyan Cui
Journal:  Sci Rep       Date:  2021-04-22       Impact factor: 4.379

4.  Large database study of urinary stone composition in South Korea: Korean Society of Endourology and Robotics (KSER) research series.

Authors:  Hae Do Jung; Ill Young Seo; Joo Yong Lee
Journal:  Investig Clin Urol       Date:  2021-07

Review 5.  Animal models of naturally occurring stone disease.

Authors:  Ashley Alford; Eva Furrow; Michael Borofsky; Jody Lulich
Journal:  Nat Rev Urol       Date:  2020-11-06       Impact factor: 16.430

Review 6.  Physiology of Hyperuricemia and Urate-Lowering Treatments.

Authors:  Caroline L Benn; Pinky Dua; Rachel Gurrell; Peter Loudon; Andrew Pike; R Ian Storer; Ciara Vangjeli
Journal:  Front Med (Lausanne)       Date:  2018-05-31

7.  Raman chemical imaging, a new tool in kidney stone structure analysis: Case-study and comparison to Fourier Transform Infrared spectroscopy.

Authors:  Vincent Castiglione; Pierre-Yves Sacré; Etienne Cavalier; Philippe Hubert; Romy Gadisseur; Eric Ziemons
Journal:  PLoS One       Date:  2018-08-03       Impact factor: 3.240

8.  Clinical Assessment of Risk Factors for Renal Atrophy After Percutaneous Nephrolithotomy.

Authors:  Yin Xiangrui; Wei Xiong; Wang Xi; Jiang Yuanbing; Qian Shenqiang; Guo Yu
Journal:  Med Sci Monit       Date:  2020-09-28

9.  Urine and stone analysis for the investigation of the renal stone former: a consensus conference.

Authors:  James C Williams; Giovanni Gambaro; Allen Rodgers; John Asplin; Olivier Bonny; Antonia Costa-Bauzá; Pietro Manuel Ferraro; Giovanni Fogazzi; Daniel G Fuster; David S Goldfarb; Félix Grases; Ita P Heilberg; Dik Kok; Emmanuel Letavernier; Giuseppe Lippi; Martino Marangella; Antonio Nouvenne; Michele Petrarulo; Roswitha Siener; Hans-Göran Tiselius; Olivier Traxer; Alberto Trinchieri; Emanuele Croppi; William G Robertson
Journal:  Urolithiasis       Date:  2020-10-13       Impact factor: 3.436

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.